# Dosing of Ketorolac in the Emergency Department

> **NCT03464461** · PHASE4 · TERMINATED · sponsor: **University of Missouri-Columbia** · enrollment: 289 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** Ketorolac

## Key facts

- **NCT ID:** NCT03464461
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-01
- **Primary completion:** 2024-05-30
- **Final completion:** 2024-05-30
- **Target enrollment:** 289 (ACTUAL)
- **Why stopped:** Pandemic related supply shortages and slowed enrollment.
- **Last updated:** 2024-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03464461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03464461, "Dosing of Ketorolac in the Emergency Department". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03464461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*